Fragmented grs polypeptide and variant thereof, and use thereof
AssigneeNibec Co., Ltd.
InventorsSunghoon KIM, Peter Charles GOUGHNOUR
Life of this patent
Estimating the term…
Loading patent…
AssigneeNibec Co., Ltd.
InventorsSunghoon KIM, Peter Charles GOUGHNOUR
Estimating the term…
The present invention relates to a fragmented GRS polypeptide and a variant thereof, and a use thereof and, more specifically, to: an isolated polypeptide consisting of 8 to 170 consecutive amino acids including amino acids 531 to 538 in the amino acid sequence represented by SEQ ID NO: 1 or a polypeptide consisting of a variant having a sequence homology of 80% or more with the polypeptide; a fusion protein and a complex comprising the polypeptide; a polynucleotide coding for the polypeptide; and a use thereof for the prevention and treatment of neoplastic diseases, the detection of cancer cells, imaging, and drug delivery.
A polypeptide consisting of:
22-23. (canceled)
(canceled)
28-31. (canceled)
(canceled)
Dependencies are inferred from the claim text.